Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial-Reference-Cited by-同舟云学术

Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial

Published:2024-07-26 Issue: Volume: Page:
ISSN:0021-5155
Container-title:Japanese Journal of Ophthalmology
language:en
Short-container-title:Jpn J Ophthalmol

Author:

Arima Mitsuru^ORCID,Inoue Hirosuke,Misumi Akiko,Tsukamoto Shoko,Matsushita Itsuka,Araki Shunsuke,Ohta Manami,Takahashi Kazumasa,Imazato Miyuki,Goto Tomoko,Aoki Yoshinori,Tagawa Koshiro,Hirose Masayuki,Fujita Yuito,Yoshida Noriko,Nakao Shintaro,Kondo Hiroyuki,Kusuhara Koichi,Kimura Kazuhiro,Hasegawa Shunji,Ikeda Yasuhiro,Kodama Yuki,Moritake Hiroshi,Ochiai Masayuki,Ohga Shouichi,Kishimoto Junji,Todaka Koji,Ieiri Ichiro,Sonoda Koh-Hei

Funder

the Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10384-024-01100-3.pdf

Reference31 articles.

1. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445–57.

2. Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(suppl 1):35–49.

3. Quinn GE, Barr C, Bremer D, Fellows R, Gong A, Hoffman R, et al. Changes in course of retinopathy of prematurity from 1986 to 2013: comparison of three studies in the United States. Ophthalmology. 2016;123:1595–600.

4. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA. 2015;314:1039–51.

5. Gilbert C, Malik ANJ, Nahar N, Das SK, Visser L, Sitati S, et al. Epidemiology of ROP update – Africa is the new frontier. Semin Perinatol. 2019;43:317–22.